Kim, H., Jung, H. A., Lee, S., Ahn, J. S., Ahn, M., Park, K., & Sun, J. (2021). Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors. Transl Lung Cancer Res.
Citación estilo ChicagoKim, Hongsik, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, and Jong-Mu Sun. "Comprehensive Evaluation of the Clinical Utility of Plasma EGFR Test in Non-small Cell Lung Cancer Patients With Acquired Resistance to First-line EGFR Inhibitors." Transl Lung Cancer Res 2021.
Cita MLAKim, Hongsik, et al. "Comprehensive Evaluation of the Clinical Utility of Plasma EGFR Test in Non-small Cell Lung Cancer Patients With Acquired Resistance to First-line EGFR Inhibitors." Transl Lung Cancer Res 2021.